Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Kurve Technology, a company that specializes in nasal drug delivery, and Dara BioSciences, a development-stage pharmaceutical company focused on the treatment of metabolic diseases and central nervous system disorders, have entered into a collaboration aimed at combining the products of both companies.
Subscribe to our email newsletter
“Dara BioSciences’ R&D is the type of leading-edge pharmaceutical science for which our devices were developed,” said Marc Giroux, chairman and CEO of Kurve Technology. “We are thrilled to be working with the innovative team at Dara.”
Kurve Technology’s ViaNase electronic atomizer intra-nasally delivers topical, systemic and nose-to-brain medical therapies with greater efficacy and efficiency than traditional nasal delivery devices such as spray pumps. According to the company, ViaNase is the first nasal drug delivery device that saturates the entire nasal cavity, allowing delivery to the paranasal sinuses.
In addition, ViaNase limits peripheral deposition of pharmaceutical formulations into the lungs or stomach.